Search

everythinglearnresearchcommunity

for

Search:↓

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Ishige sinicola extract helps bone-building cells grow and mature, which could aid in treating osteoporosis.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Heat-killed Enterococcus faecalis EF-2001 may promote hair growth and transition hair follicles to the growth phase.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

17β-Estradiol boosts allergic reactions and slows thymus aging in mice.

Hibiscus mucilage is an effective gelling agent for diclofenac diethylamine gel.

The document does not give specific results for hair loss treatment effectiveness.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Epidermal growth factor delays skin and hair development in mice.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

Erythropoietin overexpression disrupts hair growth and fat formation in mice.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Efalizumab can cause unexpected excessive hair growth.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.